Search Results

Univ Pittsburgh Commonwealth Sys Higher Education Submits United States Patent Application for T Cell Receptors Targeting Mutations in Rna Splicing Factors

• Source: Global IP News (India), February 9, 2023 Biotechnology Patent News, 2pp

Record details

INTERNATIONAL PATENT:; UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; FILES APPLICATION FOR "T CELL RECEPTORS TARGETING MUTATIONS IN RNA SPLICING FACTORS"

• Source: US Fed News (USA), June 7, 2021, 2pp

Record details

Salk Institute for Biological Studies Researchers Discover How RNA Processing Goes Awry in Rare Immune Disease

• Source: Targeted News Service: Private Colleges and Universities (USA), July 14, 2022 Education - Colleges, 4pp

Record details

University of Maryland Assigned Patent for PIM Kinase Inhibitors in Combination

• Source: Targeted News Service (USA), January 9, 2020, 2pp

Record details

U.S. Patent and Trademark Office Publishes University of Maryland Baltimore County's Patent Application for PIM Kinase Inhibitors in Combination with RNA Splicing Modulators/Inhibitors for Treatment of Cancers

• Source: Global IP News (India), March 15, 2019 Biotechnology Patent News, 2pp

Record details

H3 Biomedicine Reports Discovery of Recurrent RNA Splicing Factor Mutations in Non-Hodgkin's Lymphoma and Multiple Myeloma

• Source: ENP Newswire (UK), April 20, 2018 News, 5pp

Record details

H3 Biomedicine Reports Discovery of Recurrent RNA Splicing Factor Mutations in Non-Hodgkin's Lymphoma and Multiple Myeloma

• Authors : By:H3 Biomedicine Inc.; Media Inquiries; Liz Melone,

• Source: Business Wire, April 17, 2018, 4pp

Record details

Debiopharm Recognizes Groundbreaking Japanese Cancer Research during the 83rd Annual Meeting of the Japanese Cancer Association

• Source: ENP Newswire (UK), September 24, 2024 News, 4pp

Record details

Debiopharm Recognizes Groundbreaking Japanese Cancer Research During the 83rd Annual Meeting of the Japanese Cancer Association

• Source: Business Wire India [HT Digital] (India), September 23, 2024, 4pp

Record details

St. Jude Children's Research Hospital: HOXA9 Tracking Reveals RBM5 Dual Function and Therapeutic Potential for Acute Myeloid Leukemia

• Source: Targeted News Service (USA), January 13, 2024 Private Sector, 3pp

Record details